Selected article for: "early embryonic development and embryonic development"

Author: Saadeldin, Islam M.; Abdel-Aziz Swelum, Ayman; Alzahrani, Faisal A.; Alowaimer, Abdullah N.
Title: The current perspectives of dromedary camel stem cells research
  • Document date: 2018_2_14
  • ID: 6e2bs3k6_19
    Snippet: 1. Regenerative medicine and personalized cell therapy for traumatic, injured, or fractured elite and genetically superior camels used for show, racing or milking. 2. Camel iPSCs will be used for the genome conservation of elite genetically valuable animals, such as high milk producers, racing champions, and males of high genetic merit. 3. Understanding the functions of individual pluripotency gene overexpression on early embryonic development in.....
    Document: 1. Regenerative medicine and personalized cell therapy for traumatic, injured, or fractured elite and genetically superior camels used for show, racing or milking. 2. Camel iPSCs will be used for the genome conservation of elite genetically valuable animals, such as high milk producers, racing champions, and males of high genetic merit. 3. Understanding the functions of individual pluripotency gene overexpression on early embryonic development in camels. 4. Improving the cloning efficiency of camels through using pluripotency genes' over-expressed cell lines, either individual or combined. 5. Generating bioreactors capable of producing therapeutic targeted nanobodies for human diseases. 6. In vitro disease modeling, which could yield new insights into disease mechanisms and drug discovery, especially for orthopedics and neuronal affections pathways.

    Search related documents:
    Co phrase search for related documents
    • cell line and disease modeling: 1
    • cell line and drug discovery: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • cell line and early embryonic development: 1
    • cell line and embryonic development: 1, 2
    • cell line and express cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • cell line and human disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • cell line and new insight: 1, 2, 3, 4, 5
    • cell line and regenerative medicine: 1, 2
    • cell therapy and disease mechanism: 1, 2, 3, 4
    • cell therapy and disease modeling: 1, 2
    • cell therapy and drug discovery: 1, 2, 3, 4, 5, 6, 7
    • cell therapy and embryonic development: 1
    • cell therapy and human disease: 1, 2, 3, 4, 5, 6
    • cell therapy and new insight: 1
    • cell therapy and regenerative medicine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
    • cell therapy and traumatic cell therapy: 1